Christine Baker
Direttore/Membro del Consiglio presso TuHURA Biopharma, Inc.
Patrimonio netto: 13 023 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Christine Baker
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 16 | |
Subsidiary | Pharmaceuticals: Major | 10 | |
TuHURA Biopharma, Inc.
TuHURA Biopharma, Inc. BiotechnologyHealth Technology TuHURA Biopharma, Inc. operates as a biotechnology company. It develops bifunctional immunoconjugates for the treatment of cancer. The company was founded in 2018 and is headquartered in Seattle,WA.
1
| Private Company | Biotechnology | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Christine Baker tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
University of Notre Dame | College/University | Undergraduate Degree | |
Presage Biosciences, Inc.
Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | Medical Specialties | Chairman Chief Executive Officer | |
Health Care Systems, Inc.
Health Care Systems, Inc. Packaged SoftwareTechnology Services Health Care Systems, Inc. provides robust physician order entry and medication management solutions. The private company is based in Montgomery, AL. The CEO of the company is Erwin Cablayan. | Packaged Software | Director of Finance/CFO | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree | |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Operating Officer | |
Drexel University | College/University | Masters Business Admin | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor | |
Fairleigh Dickinson University | College/University | Masters Business Admin Masters Business Admin | |
LaSalle University | College/University | Undergraduate Degree | |
EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Director/Board Member | |
Johnson & Johnson Health Care Systems, Inc.
Johnson & Johnson Health Care Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Health Care Systems, Inc. provides account management and customer support services. The firm services include contract management, e-business and supply chain. It provides services to health care organizations, hospitals, physician networks and government customers. The company is headquartered in Piscataway, NJ | Miscellaneous Commercial Services | President Director of Finance/CFO | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Universität Salzburg | College/University | Graduate Degree | |
Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
University of Basel | College/University | Corporate Officer/Principal | |
University of Geneva | College/University | Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
The Sidney Kimmel Comprehensive Cancer Center
The Sidney Kimmel Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services The Sidney Kimmel Comprehensive Cancer Center offers immune-based treatments for cancer. The company was founded by Sidney Kimmel in 1973 and is headquartered in Baltimore, MD. | Hospital/Nursing Management | Corporate Officer/Principal | |
ParkStone Medical Info Systems | Chief Operating Officer | ||
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer | |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Founder | |
University of Zurich Medical School | College/University | Undergraduate Degree | |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Vertice Pharma LLC
Vertice Pharma LLC Pharmaceuticals: MajorHealth Technology Vertice Pharma LLC operates as a pharmaceuticals company that develops, manufactures, markets, and distributes pharmaceutical products through its operating companies. The company was founded by Donald W. DeGolyer and is headquartered in Berkeley Heights, NJ. | Pharmaceuticals: Major | Founder | |
Vertice Pharma UK Parent Ltd.
Vertice Pharma UK Parent Ltd. Pharmaceuticals: MajorHealth Technology Vertice Pharma UK Parent Ltd. engages in the activities of a holding company with interest in pharmaceutical industry. The company was founded in 2015 and is headquartered in Berkeley Heights, NJ. | Pharmaceuticals: Major | Director/Board Member | |
RELAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | Biotechnology | Director/Board Member Chief Executive Officer | |
HLS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
HotSpot Therapeutics, Inc.
HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Medical Specialties | Founder | |
Vertice Pharma UK Holdings Ltd.
Vertice Pharma UK Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of Vertice Pharma UK Parent Ltd., Vertice Pharma UK Holdings Ltd. is a pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in London, UK and was founded in 2015. | Pharmaceuticals: Major | Director/Board Member | |
Vertice Pharma UK Intermediate Ltd.
Vertice Pharma UK Intermediate Ltd. Financial ConglomeratesFinance Part of Vertice Pharma UK Parent Ltd., Vertice Pharma UK Intermediate Ltd. functions as an investment holding company. The company is based in London, UK and was founded in 2015. | Financial Conglomerates | Director/Board Member | |
Xevant, Inc.
Xevant, Inc. Packaged SoftwareTechnology Services Xevant, Inc. is a pharmacy benefits platform that automates and simplifies the process of report building for pbms, tpas, health plans, brokers, and consultants. The company is based in Lehi, UT. The platform infuses real-time automation and alerts throughout the data analysis process, resulting in optimized business processes, reduced operating costs, and improved patient outcomes. Xevant is recognized as one of Modern Healthcare's best places to work and the No. 1 fastest-growing private software company on the 2022 Inc. 5000 list. The company was founded in 2017 by Brandon Newman, who has been the CEO since 2017. | Packaged Software | Director/Board Member | |
Mablink Bioscience
Mablink Bioscience Pharmaceuticals: MajorHealth Technology Mablink Bioscience is a biotechnology company based in Lyon, France that develops next-generation antibody-drug conjugates for the treatment of solid tumors. Mablink Bioscience's exclusive PSarlink™ platform is a unique stealth technology that "masks" the hydrophobicity of the cytotoxic drugs by adding a polysarcosine chain to the linker. The French company's pipeline is built on the topoisomerase-I inhibitor exatecan as a payload for current developments. Recently, the company announced the publication of a review article titled “Payload Diversification\: A Key Step in the Development of Antibody–Drug Conjugates” which reviews the history of the successes and failures in ADC payloads and takes a look at the new roads currently explored by the industry. The company was founded in 2018 by Warren Viricel and Jean-Guillaume Lafay, with Jean-Guillaume Lafay serving as CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
Tenpoint Therapeutics Ltd.
Tenpoint Therapeutics Ltd. BiotechnologyHealth Technology Tenpoint Therapeutics Ltd. is a British biotechnology company that specializes in developing engineered cell-based therapies and in vivo reprogramming to restore vision for individuals with degenerative ocular diseases. The company is based in Cambridge, UK and was founded in 2020. Tenpoint Therapeutics brings together experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. The company's focus is on replacing diseased cells with healthy ones to permanently restore vision. Eddy Anglade has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor |
Statistiche
Distribuzione geografica
Stati Uniti | 34 |
Regno Unito | 6 |
Svizzera | 5 |
Austria | 4 |
Francia | 3 |
Settori
Health Technology | 30 |
Consumer Services | 11 |
Commercial Services | 5 |
Finance | 4 |
Technology Services | 3 |
Posizioni
Director/Board Member | 111 |
Corporate Officer/Principal | 74 |
Independent Dir/Board Member | 30 |
Chief Tech/Sci/R&D Officer | 21 |
Undergraduate Degree | 18 |
Contatti più connessi
Insiders | |
---|---|
Tim Tyson | 28 |
Graziano Seghezzi | 26 |
Donald DeGolyer | 20 |
Michael Kelly | 19 |
James A. Bianco | 17 |
Sander J. van Deventer | 17 |
Christoph S. Lengauer | 16 |
Douglas Michels | 13 |
Mary Coelho | 12 |
Malte Peters | 11 |
Matthew Beck | 10 |
Jean-Charles Soria | 10 |
Roman Necina | 9 |
James Biehl | 9 |
David P. Carberry | 9 |
- Borsa valori
- Insiders
- Christine Baker
- Connessioni Società